Cargando…
Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes
BACKGROUND: Human oligodendroglioma presents as a heterogeneous disease, primarily characterized by the isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion. Therapy development for this tumor is hindered by incomplete knowledge of somatic driving alterations and suboptimal disease classif...
Autores principales: | Wu, Fan, Yin, Yi-Yun, Fan, Wen-Hua, Zhai, You, Yu, Ming-Chen, Wang, Di, Pan, Chang-Qing, Zhao, Zheng, Li, Guan-Zhang, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772571/ https://www.ncbi.nlm.nih.gov/pubmed/36525723 http://dx.doi.org/10.1016/j.ebiom.2022.104410 |
Ejemplares similares
-
Current and Future Frontiers of Molecularly Defined Oligodendrogliomas
por: Rincon-Torroella, Jordina, et al.
Publicado: (2022) -
Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
por: Hinrichs, Benjamin H., et al.
Publicado: (2016) -
Replication Stress Defines Distinct Molecular Subtypes Across Cancers
por: Takahashi, Nobuyuki, et al.
Publicado: (2022) -
Oligodendroglioma: pathology, molecular mechanisms and markers
por: Wesseling, Pieter, et al.
Publicado: (2015) -
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes
por: Cao, Di, et al.
Publicado: (2020)